The course of Covid 19 in Inflammatory Bowel Disease: protective role of TNF antagonists Response to: Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID 19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry